Neisserial parins, the major protein constituents of the outer membrane capable of inducing antibody responses in humans, are considered to be meningococcal vaccine candidates, so it is important to map the relevant B-cell epitopes. For B-cell epitope analyses of the serotype 15 Pore protein in Neisseria meningitidis, paired sera from selected patients with systemic rneningococcal disease (SMD) were screened with synthetic 12mer peptides spanning the PorB protein sequence, andlor its variable region 1 (VR1). A 'SMD-related' linear B-cell epitope was found within the VRl region consisting of 14 residues (17svFHQNCQVTEvtt30). A 23mer soluble peptide (D63b2) that covered the V R I region, including the complete 17svFHQNGQVTEvtt30 sequence, was recognized, whereas no detectable binding was observed to a 'i6mer peptide (D63al) containing most of the essential sequence (1gFHQNGQVTEvtt30). A low frequency of IgG responses specific for the PorB linear epitopes was found in convalescent-phase sera from 132 SMD patients studied, as judged from both immunoblotting studies (24/132; l8-2%) and reactivity with peptide D63b2 (18/132; 13*6%). Peptide D63b2 significantly inhibited IgG binding to the denatured PorB protein an immunoblots, suggesting that this B-cell epitope was one of the main linear epitopes on the PorB protein recognized by sera from some SMD patients. 
INTRODUCTION
Protective immunity against systemic meningococcal disease has been ascribed to antibody-dependent bactericidal killing, and to opsonophagocytic killing by neutrophils (Figueroa & Densen, 1991 ;  Ross ef a/., 1987; Griffiss, 1982) and by tissue macrophages mainly involved in the clearance and destruction of bacteria (Benacerraf e t a/., 1959) . At present, no Abbreviations: OMP, outer-mernbrane protein; OMV, outer-membrane vesicle; SMD, systemic meningococcal disease; VR, variable region.
responses against other non-capsular surface antigens (Mandrel1 & Zollinger, 19859, which are therefore considred to be meningococcal vaccine candidates (Romero & Outschoorn, 1994) . For example, patients with sj7s-temic meningococcal disease (SbID) (Orren e t al., 1992; Mandrell & Zollinger, 1989) . In addition, SMD induced significant antibody responses to class 5 OMPs (Poolman etal., 1983 ;  Mandrel1 & Zollinger, l989), Opc protein (Rosenqvist e t a)., 1993; Achtman eta/., 19881, IgAl protcase (Brooks t i al,, 1992; Morellj et al., 19941, Lip 
Neisserial porins have attracted significant attention as major protein constituents of the outer membrane. (Blake & Gotschlich, 1986) . Studies on the classes 2 and 3 OhIPs (also designated PorB proteins) from A'eimria men2ngZtidds identified two alleles of the porB gene (Hitchcock, 1989) sharing sequence homology with other neisserial (Wolff & Stern, 1991; Ward e t a/., 1992) and Escherichzh coh' (Gotschlich et a/., 1987) porins. Molecular modelling of the topology of neisserial porins (van der Ley e t a/., 1991) predicted that the PorB molecule consisted of eight surface-exposed hydrophilic loops, with loops 1, 5 , 6 and 7 bearing four variable regions designated VR1-VR4, respectively (Bash e t at., 1395 ; Feavers eta/., 1992; Zapata e t al., 1992) . Murine PorB-specific mAbs have been reported to recognize mainly surface-exposed conformational epitopes (Delvig tt a/., 1995 ; Zapata e t al., 1992) , as did PIA-specific mAbs (Mee a t d., 1993) , and some of them were bactericidal and protective in the infant rat infection model (Saukkonen e t a/., 1987; Moran et d., 1994) . Taken together, the animal studies provided evidence that the PorB protein might also be involved in protection against SMD. Indeed, convalescent-phase sera obtained from patients with SMD showed a high rate of seroconversion to the major OMYs (PorB protein, PorA protein and class 5 OPVIP) (Poolman etal,, 1983; Mandrel1 & Zollinger, 1989) . Using the purified rneningococcal porin proteins, Guttormsen eta/. (1994b Guttormsen eta/. ( , 1993 found that SMD stimulated IgG antibodies specific for both the PorA and PorB proteins in most SMD patients, with the latter antibodies directed to surface-exposed epitopes. Furthermore, affinity-purified antibodies from patients with SMD were found to be bactericidal and opsonic (Guttormsen et al,, 1994a) (Geysen et at., 1984 The current selection was based on the pronounced reactivity of the sera with the denatured PorB protein on immunoblots (data not shown), suggesting the presence of detectable levels of antibodies reactive with linear epitopes. In addition, the protocol used allowed the study of epitopes recognized under different clinical forms of SMD.
Convalescent sera, unlike the acute-phase sera, obtained from bath patients with meningitis (K-131 from the vaccinees group, and K-194 from the placebo control group) mainly reacted with a single peptide (1gFHQNGQVTEVTT30, peptide no. 4) (Fig. 2b, c) , whilst no increased reactivity to other peptides was found. Infection induced a strong response against this l2mer peptide in the vaccinated patient I<-131 14 d after admission but no such reactivity was detected in the paired late-convalescent serum obtained 19 months later (data n o t shown). In the unvaccinated patient K-149, peptide 4 reactivity was detected in the late-convalescent serum obtained 9 months after the SMD episode, but not in the acute-phase serum taken 9 d after admission (data not shown) .
Early convalescent-phase sera (1 5-21 d) from two patients with meningococcal septicaemia (K-15 and U-17) showed two-to fivefold increases in reactivity against the majority of peptides (Fig. 2d, e) Fig-3 . ELISA reactivity of paired sera from three SMD patients with synthetic 12rner peptides on pins spanning the VR1 region. Data are presented as the difference in reactivities between immune serum versus pre-immune serum obtained a t admission from patient K-199 (a), patient K-131 (b) and patient K-54 (c).
Other details a5 in legend to Fig. 2 .
~-putative B-cell epitopes in more detail, late-convalescent sera from an additional six group K patients, which reacted with medium intensity with the denatured PorB protein on immunoblots, were subjected to epitope mapping, but no significant responses with single pep tides were detected (data not shown).
Further definition of the B-cell epitope within the VRl region
To define the linear structure of this B-cell epitope in more detail, 12mer peptides, having 11 amino acids in common, were synthesized on pins to span the VR1 region. Paired sera from only three of the abovementioned patients (K-199, K-131 and K-54) were tested. All three showed a similar pattern of reactivity (Fig. 3a-c,  respectively) . These data suggested that the B-cell epitope within the V R l region consisted of the minimal sequence '"FHQNGQVTE2' plus ''sv18 and/or z8vtt3" residues probably being essential for binding. To test this hypothesis, purified synthetic peptides corresponding to different portions of the loop 1 (VR1) region were screened with convalescent-phase sera, and essentially no reactivity was detected with peptide D63al that covered only part of rhe epitope ( ' " F H Q N G Q V T E V~~~~) (data not shown). In contrast, peptide D63b2 containing the complete B-cell epitope was eficien tly recognized by these sera; thus the complete epitope comprises the 14 amino acids 1isvFHQNGQVTEsrtt30 (Fig. 1) . Interestingly, the pin bearing peptide no. 4 with the 19FHQNGQVTEvtt3* sequence was strongly reactive with human sera. This apparent discrepancy between pinbound and free peptides might reflect some limitations of the pepscan method since high peptide concentrations on the solid-phase can facilitate bivalent reactions and crossreactivity (Van Regenmortel, 1992) .
Inhibition efficiency of peptide D63b2
To test if the ' SMD-related ' B-cell-epitope-specific IgG response was immunodominant, peptide D63b2 was added to sera from patients I<-199, I<-131 and I<-54 , and data on patient I<-54 is shown in Fig. 4 . The presence of increasing amounts of peptide D63b2 (0-004-4 nmol) resulted in a gradual partial reduction in IgG binding to the denaturcd PorB protein on immunoblots, whereas reactivities against other OTvIPs remained intact (Fig, 4 , tracks 3-6). Absorbtion of the sera with epidemic strain 44/76 resulted in complete inhibition of binding to the PorB protein (data not shown). These data are in agreement with observations by Guttormsen e t al. (1993) that the PorB-specific antibodies in SMD patients are mainly directed to surface-exposed epitopes.
Recent studies have shed light on the target antigens recognized by the immune system during infection by pathogenic Nei5serid species. In this respect, neisserial porins are receiving increasing attention as abundant components of the outer membrane (Blake 81 Gotschlich, 1986 ) capable of activating T-lymphocytes through the HLA class 11-restricted pathway (Wiertz e t al., 1991 (Wiertz e t al., , 1992 , as well as stimulating B-lymphocyte proliferation and differentiation into antibody-secreting cells (Guttormsen e t al., 1993 (Guttormsen e t al., , 1994b Wetzler e t d., 1988) . In addition, neisserial porins appear to be potent immunomodulators, and are therefore used as protein carriers in different experimental vaccines (Lowell e t al. , 1988 ; Livingston e t al., 1993; Siber, 1994) . To be effective, a peptide-based vaccine has to contain different appropriate epitapes in order to overcome the variation in immune responses resulting from histocompatibility leucocyte antigen (HLA) heterogeneity, and to induce T-and B-cell activation and differentiation (Ada, 1992 So far, information about human B-and T-cell epitopes on meningococcal antigens is limited to capsular polysaccharide (Kabat et al., 1988) , and some non-capsular antigens (Wiertz eta!., 1992 ; Delvig e b a/., 1994; de Cossio e t al., 1992; Morelli eta/., 1394). In this context, the B-cell epitope described in this report will add to the limited collection of epitopes recognized by human immune sera.
